Key learning outcomes for clinical pharmacology and therapeutics education in Europe: A modified Delphi study.

dc.contributor.authorDavid J. Brinkman
dc.contributor.authorJelle Tichelaar
dc.contributor.authorLidwine B. Mokkink
dc.contributor.authorThierry Christiaens
dc.contributor.authorRobert Likic
dc.contributor.authorRomaldas Maciulaitis
dc.contributor.authorJoao Costa
dc.contributor.authorEmilio J. Sanz
dc.contributor.authorSimon R. Maxwell
dc.contributor.authorMilan C. Richir
dc.contributor.authorMichiel A. van Agtmael
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code2607100
dc.converis.publication-id28387689
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/28387689
dc.date.accessioned2022-10-28T12:35:59Z
dc.date.available2022-10-28T12:35:59Z
dc.description.abstractHarmonizing clinical pharmacology and therapeutics (CPT) education in Europe is necessary to ensure that the prescribing competency of future doctors is of an uniform high standard. As there are currently no uniform requirements, our aim was to achieve consensus on key learning outcomes for undergraduate CPT education in Europe. We used a modified Delphi method consisting of three questionnaire rounds and a panel meeting. 129 experts from 27 European countries were asked to rate 307 learning outcomes. 92 experts (71%) completed all three questionnaire rounds, and 33 experts (26%) attended the meeting. 232 learning outcomes from the original list, 15 newly suggested and 5 rephrased outcomes were included. These 252 learning outcomes should be included in undergraduate CPT curricula to ensure that European graduates are able to prescribe safely and effectively. We provide a blueprint of a European core curriculum describing when and how the learning outcomes might be acquired. This article is protected by copyright. All rights reserved.
dc.format.pagerange325
dc.identifier.eissn1532-6535
dc.identifier.jour-issn0009-9236
dc.identifier.olddbid177590
dc.identifier.oldhandle10024/160684
dc.identifier.urihttps://www.utupub.fi/handle/11111/33801
dc.identifier.urnURN:NBN:fi-fe2021042717881
dc.language.isoen
dc.okm.affiliatedauthorHuupponen, Risto
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherWiley
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1002/cpt.962
dc.relation.ispartofjournalClinical Pharmacology and Therapeutics
dc.relation.issue2
dc.relation.volume104
dc.source.identifierhttps://www.utupub.fi/handle/10024/160684
dc.titleKey learning outcomes for clinical pharmacology and therapeutics education in Europe: A modified Delphi study.
dc.year.issued2018

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Brinkman_et_al-2018-Clinical_Pharmacology_&_Therapeutics.pdf
Size:
720.14 KB
Format:
Adobe Portable Document Format
Description:
Publisher´s PDF